These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7715801)

  • 1. Effects of naloxone, morphine and kappa-opioid receptor agonists on hypoxia/hypoglycemia-induced reduction of 2-deoxyglucose uptake in hippocampal slices from U-50,488H-tolerant rats.
    Shibata S; Tominaga K; Watanabe S
    Neurosci Lett; 1994 Dec; 182(2):155-8. PubMed ID: 7715801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. kappa-Opioid receptor agonist protects against ischemic reduction of 2-deoxyglucose uptake in morphine-tolerant rats.
    Shibata S; Tominaga K; Watanabe S
    Eur J Pharmacol; 1995 Jun; 279(2-3):197-202. PubMed ID: 7556401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of mu-, delta- and kappa-agonists on isolated right atria of the rat.
    Micol JA; Laorden ML
    Neuropeptides; 1994 Jun; 26(6):365-70. PubMed ID: 7936123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.
    Laorden ML; Castells MT; Martínez MD; Martínez PJ; Milanés MV
    Endocrinology; 2000 Apr; 141(4):1366-76. PubMed ID: 10746640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of mu and kappa opioid receptor agonists on cAMP level in hippocampus of kainic acid-treated rats.
    Dziedzicka-Wasylewska M; Przewłocki R
    Pol J Pharmacol; 1995; 47(2):121-6. PubMed ID: 8688884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitussive effects of two specific kappa-opioid agonists, U-50,488H and U-62,066E, in rats.
    Kamei J; Tanihara H; Kasuya Y
    Eur J Pharmacol; 1990 Oct; 187(2):281-6. PubMed ID: 2272363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
    Millan MJ; Morris BJ; Herz A
    J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-tolerance to acute administration of mu and kappa opioid agonists at the spinal cord level in the rat.
    Laurido C; Hernandez A; Perez H
    Int J Neurosci; 1996 Nov; 87(3-4):191-9. PubMed ID: 9003979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of kappa-opioid agonist U-50, 488H on wet-dog shaking behavior induced by hippocampal stimulation in rats.
    Ohno M; Yamamoto T; Araki H; Ueki S
    Psychopharmacology (Berl); 1987; 91(2):189-92. PubMed ID: 3107029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
    Capasso A; Sorrentino L; Pinto A
    Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist.
    Bhargava HN; Ramarao P; Gulati A
    Eur J Pharmacol; 1989 Mar; 162(2):257-64. PubMed ID: 2542058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
    Wilson JL; Nayanar V; Walker JS
    Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ibogaine and noribogaine on the antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice.
    Bhargava HN; Cao YJ; Zhao GM
    Brain Res; 1997 Mar; 752(1-2):234-8. PubMed ID: 9106462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
    Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
    J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The abilities of specific kappa-opioid agonists, U-50,488H and U-62,066E, to cause antitussive tolerance were lower than that of morphine.
    Kamei J; Tanihara H; Kasuya Y
    Jpn J Pharmacol; 1991 Aug; 56(4):557-61. PubMed ID: 1744997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of kappa-opioid receptor mechanisms in the calcitonin-induced potentiation of opioid effects at the hypothalamus-pituitary-adrenocortical axis.
    Milanés MV; Vargas ML; Martín MI
    Eur J Pharmacol; 1994 Dec; 271(1):103-9. PubMed ID: 7698193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
    Yamamoto T; Ohno M; Ueki S
    Eur J Pharmacol; 1988 Oct; 156(1):173-6. PubMed ID: 2850208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orally administered opioid antagonists reverse both mu and kappa opioid agonist delay of gastrointestinal transit in the guinea pig.
    Culpepper-Morgan JA; Holt PR; LaRoche D; Kreek MJ
    Life Sci; 1995; 56(14):1187-92. PubMed ID: 7475895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal contractures of guinea-pig isolated ileum after acute activation of kappa-opioid receptors.
    Morrone LA; Romanelli L; Amico MC; Valeri P
    Br J Pharmacol; 1993 May; 109(1):48-52. PubMed ID: 8388301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.